GigaGen's proprietary approach delivers unprecedented insights into immune regulatory pathways and what causes them to fail, enabling a pipeline of novel antibody therapies for patients with cancer and
immune deficiency diseases.
Perhaps you are inadvertently exposing them to the ravages of the 21st century illnesses:
the immune deficiency diseases.